Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of EUR 8.80 billion. The enterprise value is 10.32 billion.

Market Cap	8.80B
Enterprise Value	10.32B

Important Dates

The next estimated earnings date is Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	188.64M
Shares Outstanding	n/a
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	186.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	89.20
PS Ratio	3.36
PB Ratio	3.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 151.14, with an EV/FCF ratio of 57.44.

EV / Earnings	-10.93
EV / Sales	4.22
EV / EBITDA	151.14
EV / EBIT	n/a
EV / FCF	57.44

Financial Position

The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.06.

Current Ratio	2.73
Quick Ratio	2.12
Debt / Equity	1.06
Debt / EBITDA	32.14
Debt / FCF	13.08
Interest Coverage	-6.09

Financial Efficiency

Return on equity (ROE) is -36.89% and return on invested capital (ROIC) is -2.08%.

Return on Equity (ROE)	-36.89%
Return on Assets (ROA)	-1.83%
Return on Invested Capital (ROIC)	-2.08%
Return on Capital Employed (ROCE)	-3.40%
Revenue Per Employee	376,487
Profits Per Employee	-135,764
Employee Count	7,000
Asset Turnover	0.47
Inventory Turnover	5.61

Taxes

Income Tax	-8.22M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.13
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.78

Income Statement

In the last 12 months, Exact Sciences had revenue of EUR 2.62 billion and -943.56 million in losses. Loss per share was -5.10.

Revenue	2.62B
Gross Profit	1.83B
Operating Income	-163.65M
Pretax Income	-951.78M
Net Income	-943.56M
EBITDA	35.24M
EBIT	-163.65M
Loss Per Share	-5.10

Full Income Statement

Balance Sheet

The company has 727.37 million in cash and 2.35 billion in debt, giving a net cash position of -1.62 billion.

Cash & Cash Equivalents	727.37M
Total Debt	2.35B
Net Cash	-1.62B
Net Cash Per Share	n/a
Equity (Book Value)	2.22B
Book Value Per Share	11.76
Working Capital	802.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 299.45 million and capital expenditures -119.83 million, giving a free cash flow of 179.62 million.

Operating Cash Flow	299.45M
Capital Expenditures	-119.83M
Free Cash Flow	179.62M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.76%, with operating and profit margins of -6.25% and -36.06%.

Gross Margin	69.76%
Operating Margin	-6.25%
Pretax Margin	-36.37%
Profit Margin	-36.06%
EBITDA Margin	1.35%
EBIT Margin	-6.25%
FCF Margin	6.86%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	n/a
Earnings Yield	-10.72%
FCF Yield	2.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.33
Piotroski F-Score	5